A carregar...
Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
This multicenter, randomized, double-blind, placebo-controlled study assessed ambrisentan or placebo in patients with inoperable chronic thromboembolic pulmonary hypertension. Futility of enrollment led to early termination. Trends of improvement in favor of ambrisentan versus placebo in the primary...
Na minha lista:
| Publicado no: | Pulm Circ |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6540507/ https://ncbi.nlm.nih.gov/pubmed/30957635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894019846433 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|